Viewing Study NCT05392751

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:49 PM

Ignite Modification Date: 2025-12-25 @ 9:44 PM

Study NCT ID: NCT05392751

Status: TERMINATED

Last Update Posted: 2024-10-15

First Post: 2022-05-23

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa

Sponsor: Endogena Therapeutics, Inc

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module